International Clinical Trial: A Prospective, Randomized, Double-blinded, Controlled, Split-face, Non-inferiority Clinical Investigation Comparing the Safety and Performance of RefillHA Solid With Hydryalix Ultra Deep Lidocaine for the Correction of Moderate-to-severe Nasolabial Folds

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07736703) titled 'A Prospective, Randomized, Double-blinded, Controlled, Split-face, Non-inferiority Clinical Investigation Comparing the Safety and Performance of RefillHA Solid With Hydryalix Ultra Deep Lidocaine for the Correction of Moderate-to-severe Nasolabial Folds' on July 26.

Study Type: Observational

Primary Sponsor: Glyance

Condition: Wrinkles and Folds

Recruitment Status: Not recruiting

Date of First Enrollment: December 8, 2024

Target Sample Size: 12

Countries of Recruitment: Israel

To know more, visit https://clinicaltrials.gov/study/NCT07736703

Disclaimer: Curated by HT Syndication....